| 688137 Stock | | | 32.48 0.59 1.78% |
Suzhou Novoprotein financial indicator trend analysis is much more than just breaking down Suzhou Novoprotein prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Suzhou Novoprotein is a good investment. Please check the relationship between Suzhou Novoprotein Reconciled Depreciation and its Selling General Administrative accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Suzhou Novoprotein Reconciled Depreciation account and
Selling General Administrative. At this time, the significance of the direction appears to have totally related.
The correlation between Suzhou Novoprotein's Reconciled Depreciation and Selling General Administrative is 0.99. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Suzhou Novoprotein Scientific, assuming nothing else is changed. The correlation between historical values of Suzhou Novoprotein's Reconciled Depreciation and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Suzhou Novoprotein Scientific are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Reconciled Depreciation i.e., Suzhou Novoprotein's Reconciled Depreciation and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | 0.99 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Most indicators from Suzhou Novoprotein's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Suzhou Novoprotein current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The current year's
Tax Provision is expected to grow to about (5.7
M). In addition to that, Selling General Administrative is expected to decline to about 55.3
MBalance Sheet is a snapshot of the
financial position of Suzhou Novoprotein at a specified time, usually calculated after every quarter, six months, or one year. Suzhou Novoprotein Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Suzhou Novoprotein and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Suzhou currently owns. An asset can also be divided into two categories, current and non-current.